The renaissance of T regulatory cells: Looking for markers in a haystack

Inmunologia

Volumn 26, Issue 2, 2007, Pages 100-107

  Pini, E ^a   Ojeda, G ^a   Portolés, Pilar ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Adenosine; cAMP; CD37; CD39; Nucleotidases; T regulatory cells; Treg

Indexed keywords

CELL DIFFERENTIATION; CELL POPULATION; IMMUNE RESPONSE; PHENOTYPE; REGULATORY T LYMPHOCYTE; REVIEW; THYMUS;

EID: 35348948926     PISSN: 02139626     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0213-9626(07)70080-X     Document Type: Article

References (52)

1. Gershon RK, Kondo K. Cell interactions in the induction of tolerance: The role of thymic lymphocytes. Immunology 1970;18:723-737.
2. Cantor H. Reviving suppression? Nat Immunol 2004;5:347-349.
3. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-1164.
4. McGuirk P, Mills KHG. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol 2002;23:450-455.
5. + regulatory T cells in autoimmunity and allergy. Curr Opinion Immunol 2002;14:771-778.
6. + T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med 2002;196:1335-1346.
7. Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 1996;98:70-77.
8. Inobe J, Slavin AJ, Komagata Y, Chen Y, Liu L, Weiner HL. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur J Immunol 1998;28:2780-2790.
9. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004;22:531-562.
10. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-1061.
11. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005;22:329-341.
12. Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, Beavo JA et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007;445:771-775.
13. Zheng Y, Rudensky AY. Foxp3 in control of the regulatory T cell lineage. Nat Immunol 2007;8:457-462.
14. Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan AD, Stroud JC et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006;126:375-387.
15. + T regulatory cells. Nat Immunol 2003;4:337-342.
16. + regulatory T cells. Nat Immunol 2003;4:330-336.
17. Mantel PY, Ouaked N, Ruckert B, Karagiannidis C, Welz R, Blaser K et al. Molecular mechanisms underlying FOXP3 induction in human T cells. J Immunol 2006;176:3593-3602.
18. - T cells. J Clin Invest 2003;112:1437-1443.
19. + regulatory T cells in aged BALB/c mice. J Leukoc Biol 2007;81:1386-1394.
20. Miyara M, Sakaguchi S. Natural regulatory T cells: Mechanisms of suppression. Trends Mol Med 2007;13:108-116.
21. Shevach EM, Stephens GL. The GITR-GITRL interaction: Costimulation or contrasuppression of regulatory activity? Nat Rev Immunol 2006;6:613-618.
22. + immunoregulatory T cells: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002;16:311-323.
23. + regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002;3:135-142.
24. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003;197:403-411.
25. Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, Loser K et al. Neuropilin-1: A surface marker of regulatory T cells. Eur J Immunol 2004;34:623-630.
26. Lim HW, Hillsamer P, Kim CH. Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses. J Clin Invest 2004;114:1640-1649.
27. - regulatory T cells. Proc Natl Acad Sci USA 2002;99:13031-13036.
28. + regulatory T cells. J Exp Med 2001;194:847-854.
29. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000;12:431-440.
30. + regulatory T cells in inflamed synovia. J Exp Med 2005;201:1793-1803.
31. + T reg cells. J Exp Med 2006;203:1701-1711.
32. + regulatory T cells that express toll-like receptors. J Exp Med 2003;197:397-401.
33. + regulatory T cells control Leishmania major persistence and immunity. Nature 2002;420:502-507.
34. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007;204:1257-1265.
35. + immunoregulatory T cells is antigen nonspecific. J Immunol 2000;164:183-190.
36. + regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: Antigen-specific reactivation in vivo is critical for bystander regulation. Blood 2005;105:4871-4877.
37. + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998;10:1969-1980.
38. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting Interleukin 2 production. J Exp Med 1998;188:287-296.
39. Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, Vacca C et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol 2006;176:6752-6761.
40. Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005;6:331-337.
41. Bopp T, Becker C, Klein M, Klein-Hessling S, Palmetshofer A, Serfling E et al. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 2007;204:1303-1310.
42. Sitkovsky MV, Ohta A. The 'danger' sensors that STOP the immune response: The A2 adenosine receptors? Trends Immunol 2005;26:299-304.
43. Huang S, Apasov S, Koshiba M, Sitkovsky M. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 1997;90:1600-1610.
44. Armstrong JM, Chen JF, Schwarzschild MA, Apasov S, Smith PT, Caldwell C et al. Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes: Studies of cells from A2A-receptor-gene-deficient mice. Biochem J 2001;354:123-130.
45. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 2001;414:916-920.
46. Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MK et al. A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci USA 2006;103:13132-13137.
47. Naganuma M, Wiznerowicz EB, Lappas CM, Linden J, Worthington MT, Ernst PB. Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis. J Immunol 2006;177:2765-2769.
48. Resta R, Yamashita Y, Thompson LF. Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol Rev 1998;161:95-109.
49. Kobie JJ, Shah PR, Yang L, Rebhahn JA, Fowell DJ, Mosmann TR. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine. J Immunol 2006;177:6780-6786.
50. Erdmann AA, Gao ZG, Jung U, Foley J, Borenstein T, Jacobson KA et al. Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo. Blood 2005;105:4707-4714.
51. Bodor J, Feigenbaum L, Bodorova J, Bare C, Reitz MS, Jr., Gress RE. Suppression of T-cell responsiveness by inducible cAMP early repressor (ICER). J Leukoc Biol 2001;69:1053-1059.
52. Sitkovsky MV, Lukashev D, Apasov S, Kojima H, Koshiba M, Caldwell C et al. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol 2004;22:657-682.